Cargando…

Direct and Allosteric Inhibition of the FGF2/HSPGs/FGFR1 Ternary Complex Formation by an Antiangiogenic, Thrombospondin-1-Mimic Small Molecule

Fibroblast growth factors (FGFs) are recognized targets for the development of therapies against angiogenesis-driven diseases, including cancer. The formation of a ternary complex with the transmembrane tyrosine kinase receptors (FGFRs), and heparan sulphate proteoglycans (HSPGs) is required for FGF...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pagano, Katiuscia, Torella, Rubben, Foglieni, Chiara, Bugatti, Antonella, Tomaselli, Simona, Zetta, Lucia, Presta, Marco, Rusnati, Marco, Taraboletti, Giulia, Colombo, Giorgio, Ragona, Laura
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3351436/ https://www.ncbi.nlm.nih.gov/pubmed/22606323 http://dx.doi.org/10.1371/journal.pone.0036990

Ejemplares similares

Thrombospondin-1 as a Paradigm for the Development of Antiangiogenic Agents Endowed with Multiple Mechanisms of Action
por: Rusnati, Marco, et al.
Publicado: (2010)

Integrating computational and chemical biology tools in the discovery of antiangiogenic small molecule ligands of FGF2 derived from endogenous inhibitors
por: Foglieni, Chiara, et al.
Publicado: (2016)

Targeting tumor angiogenesis with TSP-1-based compounds: rational design of antiangiogenic mimetics of endogenous inhibitors
por: Taraboletti, Giulia, et al.
Publicado: (2010)

Inhibition of FGFR Signaling by Targeting FGF/FGFR Extracellular Interactions: Towards the Comprehension of the Molecular Mechanism through NMR Approaches
por: Pagano, Katiuscia, et al.
Publicado: (2022)

Exploiting Surface Plasmon Resonance (SPR) Technology for the Identification of Fibroblast Growth Factor-2 (FGF2) Antagonists Endowed with Antiangiogenic Activity
por: Rusnati, Marco, et al.
Publicado: (2009)

Fibroblast growth factor 2-antagonist activity of a long-pentraxin 3-derived anti-angiogenic pentapeptide
por: Leali, Daria, et al.
Publicado: (2010)

A long pentraxin-3-derived pentapeptide for the therapy of FGF8b-driven steroid hormone-regulated cancers
por: Giacomini, Arianna, et al.
Publicado: (2015)

Inhibition of the FGF/FGFR System Induces Apoptosis in Lung Cancer Cells via c-Myc Downregulation and Oxidative Stress
por: Giacomini, Arianna, et al.
Publicado: (2020)

Regulation of stem cell fate by HSPGs: implication in hair follicle cycling
por: Colin-Pierre, Charlie, et al.
Publicado: (2022)

Natural Compounds as Inhibitors of Aβ Peptide Aggregation: Chemical Requirements and Molecular Mechanisms
por: Pagano, Katiuscia, et al.
Publicado: (2020)

Tau Internalization is Regulated by 6-O Sulfation on Heparan Sulfate Proteoglycans (HSPGs)
por: Rauch, Jennifer N., et al.
Publicado: (2018)

The Autocrine FGF/FGFR System in both Skin and Uveal Melanoma: FGF Trapping as a Possible Therapeutic Approach
por: Rezzola, Sara, et al.
Publicado: (2019)

Role of the soluble pattern recognition receptor PTX3 in vascular biology
por: Presta, Marco, et al.
Publicado: (2007)

FGF7/FGFR2 signal promotes invasion and migration in human gastric cancer through upregulation of thrombospondin-1
por: Huang, Tingting, et al.
Publicado: (2017)

Bile acid binding protein: a versatile host of small hydrophobic ligands for applications in the fields of MRI contrast agents and bio-nanomaterials
por: Pagano, Katiuscia, et al.
Publicado: (2013)

Heparin/Heparan Sulfate Proteoglycans Glycomic Interactome in Angiogenesis: Biological Implications and Therapeutical Use
por: Chiodelli, Paola, et al.
Publicado: (2015)

Antiangiogenic activity of aplidine, a new agent of marine origin
por: Taraboletti, G, et al.
Publicado: (2004)

Resistance to allosteric SHP2 inhibition in FGFR-driven cancers through rapid feedback activation of FGFR
por: Lu, Hengyu, et al.
Publicado: (2020)

Heparan sulfate proteoglycans (HSPGs) and chondroitin sulfate proteoglycans (CSPGs) function as endocytic receptors for an internalizing anti-nucleic acid antibody
por: Park, Hyunjoon, et al.
Publicado: (2017)

Heparan Sulfate Proteoglycans (HSPGs) Serve as the Mediator Between Monomeric Tau and Its Subsequent Intracellular ERK1/2 Pathway Activation
por: Song, Liqing, et al.
Publicado: (2022)

Differential Specificity of Endocrine FGF19 and FGF21 to FGFR1 and FGFR4 in Complex with KLB
por: Yang, Chaofeng, et al.
Publicado: (2012)

FGF/FGFR signaling in health and disease
por: Xie, Yangli, et al.
Publicado: (2020)

Phagocyte Transcriptomic Analysis Reveals Focal Adhesion Kinase (FAK) and Heparan Sulfate Proteoglycans (HSPGs) as Major Regulators in Anti-bacterial Defense of Crassostrea hongkongensis
por: Lin, Yue, et al.
Publicado: (2020)

Thrombospondins and synaptogenesis★
por: Wang, Bin, et al.
Publicado: (2012)

Investigating the Dynamic Aspects of Drug-Protein Recognition through a Combination of MD and NMR Analyses: Implications for the Development of Protein-Protein Interaction Inhibitors
por: Meli, Massimiliano, et al.
Publicado: (2014)

Role of thrombospondin-1 and thrombospondin-2 in cardiovascular diseases (Review)
por: Zhang, Kaijie, et al.
Publicado: (2020)

FGF23/FGFR4-mediated left ventricular hypertrophy is reversible
por: Grabner, Alexander, et al.
Publicado: (2017)

Expression of FGF8, FGF18, and FGFR4 in Gastroesophageal Adenocarcinomas
por: Jomrich, Gerd, et al.
Publicado: (2019)

Investigating allosteric effects on the functional dynamics of β2-adrenergic ternary complexes with enhanced-sampling simulations
por: Saleh, Noureldin, et al.
Publicado: (2017)

Unleashing the potential of combining FGFR inhibitor and immune checkpoint blockade for FGF/FGFR signaling in tumor microenvironment
por: Ruan, Ruiwen, et al.
Publicado: (2023)

Targeting the Oncogenic FGF-FGFR Axis in Gastric Carcinogenesis
por: Zhang, Jinglin, et al.
Publicado: (2019)

FGF19–FGFR4 Signaling in Hepatocellular Carcinoma
por: Raja, Aroosha, et al.
Publicado: (2019)

Surface charge changes in spike RBD mutations of SARS-CoV-2 and its variant strains alter the virus evasiveness via HSPGs: A review and mechanistic hypothesis
por: Zhang, Zhongyun, et al.
Publicado: (2022)

Antiangiogenic therapy
por: Avitabile, T
Publicado: (2010)

Identification and characterization of thrombospondin-4, a new member of the thrombospondin gene family
Publicado: (1993)

Modulation of the extracellular matrix patterning of thrombospondins by actin dynamics and thrombospondin oligomer state
por: Hellewell, Andrew L., et al.
Publicado: (2015)

UniPR1331, a small molecule targeting Eph/ephrin interaction, prolongs survival in glioblastoma and potentiates the effect of antiangiogenic therapy in mice
por: Festuccia, Claudio, et al.
Publicado: (2018)

Expression Atlas of FGF and FGFR Genes in Pancancer Uncovered Predictive Biomarkers for Clinical Trials of Selective FGFR Inhibitors
por: Li, Yuan, et al.
Publicado: (2020)

IRES-targeting small molecule inhibits enterovirus 71 replication via allosteric stabilization of a ternary complex
por: Davila-Calderon, Jesse, et al.
Publicado: (2020)

Investigating dynamic and energetic determinants of protein nucleic acid recognition: analysis of the zinc finger zif268-DNA complexes
por: Torella, Rubben, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_35ep1k2vgi88cpgku9akgn3sc8